• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Target ALS

Leading global ALS research nonprofit breaking down barriers to find effective treatments

  • DONATE
  • About Us
    • Our Mission
    • Our Model
    • Our Impact
    • Our Founder
    • Our Team
    • Our Partners
  • For Scientists
    • Research Cores
      • Target ALS Data Engine
      • Longitudinal Biofluids Core
      • Human Postmortem Tissue Core
      • Stem Cell Core
      • Reagents Core
      • Animal Models Core
    • Funding Opportunities
    • Funded Projects
    • Annual Meeting
    • Science on Target Blog
    • FAQs for Researchers
  • Understanding ALS
    • About ALS
    • Understanding the Science
      • Glossary
      • FAQ
      • ALS 101
    • Voices of ALS
    • Video Library
  • Take Action
    • Ending ALS Starts with You
    • Support Geoff Greulich
    • The ALS Global Research Initiative (AGRI)
      • Global Natural History Study
      • Community Based Pop-Up Clinics
    • Fundraise for ALS Research
    • Ways to Give
    • Email Sign Up
    • Contact Us
    • Donate Now
  • News
    • Announcements
    • In the News
    • Newsletters & Reports

Neurodegenerative Disease

Dan Doctoroff: From Transforming New York City to Building a World Where Everyone with ALS Lives 

Melissa Rentfrow · Dec 13, 2024 ·

Target ALS Attends NEALS Conference: Insights into Groundbreaking Research

Melissa Rentfrow · Nov 26, 2024 ·

A Labor of Love: Theresa Whitlock-Wild’s Unwavering Commitment to Families Affected by ALS

Melissa Rentfrow · Nov 20, 2024 ·

Addressing Inequities in ALS Healthcare: The Critical Need for Diversity in Research

Melissa Rentfrow · Nov 13, 2024 ·

Veterans and ALS: A Critical Population for Advancing Research

Melissa Rentfrow · Nov 8, 2024 ·

Breaking Down Barriers in ALS Research: New Validated pTDP-43 Antibody Now Available Globally

Melissa Rentfrow · Nov 6, 2024 ·

Five Innovative Collaborative Projects Awarded Biomarker Consortia Grant Funding

Melissa Rentfrow · Nov 6, 2024 ·

Two Studies Awarded Funding to Accelerate Novel ALS Therapies Through In-Vivo Proof-of-Concept

Melissa Rentfrow · Oct 28, 2024 ·

Target ALS Partners with ZEPHYRx to Enhance Global ALS Research Through Data Integration

Melissa Rentfrow · Oct 23, 2024 ·

Researcher looking through a microscope in a laboratory.
  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 7
  • Go to Next Page »

Footer

Target ALS
  • Donate
  • Contact
  • Financial Reports
  • Call For Proposals
  • Annual Meeting
  • Privacy Policy
  • Credits

Follow Us

We are a 501(c)(3) public charity (EIN: 81-0756743), eligible to receive tax-deductible contributions that directly support our mission to break down barriers to ALS research to find effective treatments.

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

© 2023 Target ALS Foundation, Inc.
Target ALS Foundation
244 Madison Avenue #1025
New York, NY 10016
(332) 333-4140
Steck Insights WordPress Consulting